Abiomed Inc (ABMD) 123.53 $ABMD ABIOMED Falls 1.77% on

New Post Public Reply Private Reply Replies (0) Message Board

Sep 25, 2016 at 1:19 PM

Abiomed Inc (ABMD) 123.53 $ABMD

ABIOMED Falls 1.77% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Fri Sep 23, 1:55PM CDT
ABIOMED (NASDAQ:ABMD) traded in a range yesterday that spanned from a low of $123.06 to a high of $126.09. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of $124.43 on volume of 173,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ABMD: 123.53 (-2.84)

CryoLife Hits a 52-Week High on Strong Growth Prospects
Zacks Equity Research - Zacks Investment Research - Fri Sep 23, 8:25AM CDT
Share price of CryloLife, Inc. (CRY), a leading medical device and tissue processing company, scaled a new 52-week high of $18.64 on Sep 22, eventually closing a bit lower at $18.56.
ABMD: 123.53 (-2.84), MASI: 59.77 (-0.55), IDXX: 111.36 (-1.73), CRY: 18.14 (-0.42)

ABIOMED Has Returned 50.7% Since SmarTrend Recommendation (ABMD)
Comtex SmarTrend(R) - Thu Sep 22, 12:52PM CDT
SmarTrend identified an Uptrend for ABIOMED (NASDAQ:ABMD) on March 7th, 2016 at $84.30. In approximately 7 months, ABIOMED has returned 50.65% as of today's recent price of $127.00.
ABMD: 123.53 (-2.84)

Thermo Fisher Adds FEI Co., Inorganic Expansion Continues
Zacks Equity Research - Zacks Investment Research - Tue Sep 20, 6:57AM CDT
Thermo Fisher Scientific, Inc. (TMO) recently closed the acquisition of FEI Company, Inc.
ABMD: 123.53 (-2.84), TMO: 157.66 (unch), CPHD: 52.50 (unch), CRY: 18.14 (-0.42)

Watch for ABIOMED to Potentially Pullback After Gaining 3.39% Yesterday
Comtex SmarTrend(R) - Thu Sep 15, 3:32PM CDT
ABIOMED (NASDAQ:ABMD) traded in a range yesterday that spanned from a low of $118.09 to a high of $122.98. Yesterday, the shares gained 3.4%, which took the trading range above the 3-day high of $119.48 on volume of 173,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ABMD: 123.53 (-2.84)

40.6% Return Seen to Date on SmarTrend ABIOMED Call (ABMD)
Comtex SmarTrend(R) - Thu Sep 15, 12:23AM CDT
SmarTrend identified an Uptrend for ABIOMED (NASDAQ:ABMD) on March 7th, 2016 at $84.30. In approximately 6 months, ABIOMED has returned 40.59% as of today's recent price of $118.52.
ABMD: 123.53 (-2.84)

ABIOMED Up 40.3% Since SmarTrend Uptrend Call (ABMD)
Comtex SmarTrend(R) - Wed Sep 07, 1:07PM CDT
SmarTrend identified an Uptrend for ABIOMED (NASDAQ:ABMD) on March 7th, 2016 at $84.30. In approximately 6 months, ABIOMED has returned 40.30% as of today's recent price of $118.28.
ABMD: 123.53 (-2.84)

Technical Roundup on Medical Appliances & Equipment Stocks -- Zimmer Biomet, Stryker, ABIOMED, and Spectranetics
PR Newswire - Thu Aug 18, 7:31AM CDT
Stock-Callers.com is currently focused on the Medical Appliances and Equipment segment, which includes companies that manufacture medical supplies such as surgical and medical instruments, dental equipment, and surgical appliances. According to IBISWorld, global revenue of this industry is about $350 billion. Let us take a look at today's lineup: Zimmer Biomet Holdings Inc. (NYSE: ZBH), Stryker Corp. (NYSE: SYK), ABIOMED Inc. (NASDAQ: ABMD), and The Spectranetics Corp. (NASDAQ: SPNC). Sign up today and download for free the research reports for the stocks covered today at:
SPNC: 24.24 (-0.56), ABMD: 123.53 (-2.84), ZBH: 128.33 (-0.54), SYK: 117.76 (-0.68)

ABIOMED Set to Possibly Pullback After Yesterday's Rally of 2.63%
Comtex SmarTrend(R) - Tue Aug 09, 2:56PM CDT
ABIOMED (NASDAQ:ABMD) traded in a range yesterday that spanned from a low of $120.81 to a high of $123.93. Yesterday, the shares gained 2.6%, which took the trading range above the 3-day high of $122.98 on volume of 292,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ABMD: 123.53 (-2.84)

ABIOMED Shares Up 41.9% Since SmarTrend's Buy Recommendation (ABMD)
Comtex SmarTrend(R) - Mon Aug 08, 12:48PM CDT
SmarTrend identified an Uptrend for ABIOMED (NASDAQ:ABMD) on March 7th, 2016 at $84.30. In approximately 5 months, ABIOMED has returned 41.87% as of today's recent price of $119.60.
ABMD: 123.53 (-2.84)

Weight Watchers (WTW) Misses Q2 Earnings, Stock Down
Zacks Equity Research - Zacks Investment Research - Mon Aug 08, 9:00AM CDT
Weight Watchers International Inc. (WTW) reported earnings of 46 cents per share, which missed the Zacks Consensus Estimate by 3 cents.
ABMD: 123.53 (-2.84), MASI: 59.77 (-0.55), NTRI: 29.59 (-0.84), WTW: 10.44 (-0.26)

Acadia Healthcare (ACHC) Beats on Q2 Earnings & Revenues
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 9:34AM CDT
Shares of Acadia Healthcare Company Inc have had a crazy run since the company posted second-quarter 2016 results on Jul 29.
ACHC: 49.54 (-0.78), HCA: 76.12 (-0.26), ABMD: 123.53 (-2.84), WOOF: 67.51 (-2.14)

Abiomed (ABMD) Beats Q1 Earnings & Revenues, Shares Up
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 7:35AM CDT
Abiomed reported earnings of 29 cents per share, which beat the Zacks Consensus Estimate by 7 cents.
BABY: 43.99 (-0.39), ABMD: 123.53 (-2.84), MASI: 59.77 (-0.55), CPHD: 52.50 (unch)

SmarTrend Watching for Potential Pullback in Shares of ABIOMED After 3.56% Gain
Comtex SmarTrend(R) - Fri Jul 29, 3:02PM CDT
ABIOMED (NASDAQ:ABMD) traded in a range yesterday that spanned from a low of $115.24 to a high of $119.93. Yesterday, the shares gained 3.6%, which took the trading range above the 3-day high of $116.45 on volume of 462,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ABMD: 123.53 (-2.84)

Cepheid's (CPHD) Q2 Loss Narrower than Estimate, View Up
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 2:09PM CDT
Cepheid (CPHD) posted second-quarter 2016 adjusted loss per share of 9 cents.
BABY: 43.99 (-0.39), ABMD: 123.53 (-2.84), MASI: 59.77 (-0.55), CPHD: 52.50 (unch)

GNC Holdings (GNC) Tops Q2 Earnings, Suspends '16 View
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 2:01PM CDT
GNC Holdings (GNC) ended second-quarter 2016 on a disappointing note as its revenue figure failed to meet the Zacks Consensus Estimate.
BABY: 43.99 (-0.39), ABMD: 123.53 (-2.84), MASI: 59.77 (-0.55), GNC: 20.15 (-0.20)

Shares of ABMD Up 42.2% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Jul 29, 12:54PM CDT
SmarTrend identified an Uptrend for ABIOMED (NASDAQ:ABMD) on March 7th, 2016 at $84.30. In approximately 5 months, ABIOMED has returned 42.24% as of today's recent price of $119.91.
ABMD: 123.53 (-2.84)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

High-Grade Copper Spurs Optimism for PolarX in Alaska

Copper's New Pulse: PolarX Makes Waves in Alaska Ever hear about striking copper so rich it's practically shimmering? Well, PolarX Limited just might have hit that sweet spot up in the rugged expanses of Alaska. Let me tell you, when you're knee-deep in resources, like what they’re discovering at the Caribou Dome Project, it sure feels like you’ve struck modern-day...

Melissa Rivers Brings Her Wit Back to Emmys Carpet

They say you can never go home again, but don't tell that to Melissa Rivers. Rolling the dice on nostalgia and kicking off a new chapter, she's waltzing back to the Emmys red carpet for the first time in nearly 20 years. Alright, what's in it for investors? Not much—unless you're looking to invest in nostalgia. But there's something here about legacy, reinvention, and...

QuickFi Nabs Top Finovate Award for Fourth Time

An Unstoppable Force in Fintech Well, if QuickFi hasn't made a name for itself in fintech, then folks, I don't know what to tell you. This year, they’ve snagged yet another prestigious Finovate Award—this time for Best SMB/SME Banking Solution. That's not their first rodeo either; it’s the fourth time they’ve walked away winners. It's almost like they're...

Fermi's Founder Pushes for Board Overhaul: What's Next?

Fermi's Roller Coaster: A Founder’s Stand Seems like Fermi Inc. is on a wild ride through the business landscape, and it's giving shareholders more whiplash than satisfaction these days. Toby Neugebauer, co-founder of Fermi and the loudest voice in the room, is feeling like his company is facing some serious turbulence and seems determined not to sit idly by as it hits...

Oil Markets Shift Focus: Pipelines Trump Drilling

Decoupling Oil Price and Production Response This oil market isn’t your usual rodeo. With Brent flirting with $100, it’s a seismic shift that’s not yielding new drills but redirecting capital to the existing infrastructure landscape. Ask yourself why we're not seeing the usual cavalry charge of new rigs. It’s simple: Pipeline mileage and producing wells have...

Jari Spirits Set to Shake Up U.S. Market After Big Wins

Korean Spirits Jari Eyes U.S. Market Entry Some stories just have that perfect 'right time, right place' vibe, and CJ Foods' recent splash with their Korean spirits brand jari is one of them. Buckle up, because this one's about a Korean distilling sensation gearing up to hit American shores with a bang. Accolades Pave the Path Jari, the premium Korean distilled spirits...

Supply Maverick Simplifies Global Shipping Processes

Paving the Way for Seamless International Shipping Supply Maverick's got a new mantra, folks: simplicity. They're slicing through the mess of international shipping and bringing some much-needed clarity for customers in Canada, Australia, and New Zealand. It’s about time someone shook up the logistics playbook. The Nuts and Bolts of the New Shipping System Imagine being...

DCM Services Teams with AKUVO to Boost Estate Recoveries

Revolutionizing Estate Recovery Practices Here's the scoop: DCM Services (DCMS), that big shot in estate account resolution, is hooking up with AKUVO to shake up how credit unions handle estate recoveries. This alliance is a clear nod to modernizing a process stuck in the past. Let’s face it, handling decedent and probate accounts is no cakewalk, and traditional methods...

Americas Cardroom's Poker Series Hits $7.2M Haul

Massive Prize Pools Emerge in Just Four Days I found myself eyeballing some jaw-dropping numbers from Americas Cardroom's latest poker series, the Online Super Series XL. It's not every day you see nearly a hundred tournaments rake in over $7.2 million in prize pools in just four days. From September 6th to 9th, a whopping 62,847 entries signed up to make an honest...

Intus Bio Secures $2.7M for Colorectal Cancer Test

Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...